A Phase IIIb, Multicentre, Open-Label, Randomized, Controlled Study of the Efficacy, Safety and Population Pharmacokinetics of Sapropterin Dihydrochloride (Kuvan®) in Phenylketonuria (PKU Patient <4 Years Old. SPARK (Safety Paediatric efficAcy phaRmacokin
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/01/2012 - 31/12/2014
Description
Keywords: Studie
Funding identifier: EMR700773-003
Funder / funding scheme:
- Icon Clinical Research Limited
Project management at the University of Münster
| Rutsch, Frank | University Children's Hospital - Department for General Paediatrics |
Applicants from the University of Münster
| Rutsch, Frank | University Children's Hospital - Department for General Paediatrics |